HIF-1alpha mRNA and protein upregulation involves Rho GTPase expression during hypoxia in renal cell carcinoma

Sandra Turcotte1, Richard R Desrosiers, Richard Béliveau

  • 1Laboratoire de médecine moléculaire, Hôpital Sainte-Justine, Université du Québec à Montréal, CP 8888, Succursale centre-ville, Montréal, Québec, Canada H3C 3P8.

Insights

Hypoxia increases Rho protein expression and activity in renal cell carcinoma, a process dependent on reactive oxygen species (ROS). Active RhoA is crucial for hypoxia-inducible factor 1-alpha (HIF-1α) accumulation, impacting tumor growth.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Research

Background:

  • Rho family GTPases regulate actin cytoskeleton, cell migration, and gene transcription.
  • Hypoxia disrupts actin organization and impacts Rho protein functions.
  • Tumor hypoxia stimulates angiogenesis via hypoxia-inducible factor 1 (HIF-1) and vascular endothelial growth factor (VEGF).

Purpose of the Study:

  • Investigate Rho protein activity during hypoxia in renal cell carcinoma.
  • Determine the role of Rho proteins in hypoxia-induced signaling pathways.
  • Elucidate the relationship between reactive oxygen species (ROS), Rho proteins, and HIF-1α accumulation.

Main Methods:

  • Exposed Caki-1 cells to hypoxia (1% O2).
  • Analyzed Rho protein (Cdc42, Rac1, RhoA) expression and activation using immunoprecipitation and pull-down assays.
  • Assessed RhoA mRNA levels via RT-PCR.
  • Investigated the role of ROS using inhibitors.
  • Evaluated the effect of RhoA inhibition (C3 toxin) on HIF-1α accumulation.

Main Results:

  • Hypoxia increased Cdc42, Rac1, and RhoA protein expression and activation in Caki-1 cells.
  • RhoA overexpression resulted from de novo synthesis and was regulated at the mRNA level.
  • Rho protein upregulation and activation were dependent on ROS production.
  • Inhibition of RhoA significantly reduced HIF-1α protein accumulation during hypoxia.

Conclusions:

  • Hypoxia induces ROS production, which upregulates Rho protein expression and activity in renal cell carcinoma.
  • Active RhoA is essential for HIF-1α accumulation under hypoxic conditions.
  • These findings suggest a novel regulatory pathway involving ROS and RhoA in tumor hypoxia response.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...